LYMPHANGIOLEIOMYOMATOSIS

Clinical trials for LYMPHANGIOLEIOMYOMATOSIS explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOLEIOMYOMATOSIS trials appear

Sign up with your email to follow new studies for LYMPHANGIOLEIOMYOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 2 Completed 1

Scientists hunt for blood clues to perfect dose for devastating lung disease

Knowledge-focused Completed

This study aimed to find clues in blood and urine that could help doctors determine the best dose of the drug sirolimus for women with LAM, a rare and progressive lung disease. Researchers followed 33 women who were starting sirolimus treatment, collecting samples after their fir…

Matched conditions: LYMPHANGIOLEIOMYOMATOSIS

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:29 UTC

LYMPHANGIOLEIOMYOMATOSIS

Get alerted when new LYMPHANGIOLEIOMYOMATOSIS trials appear

Scientists hunt for blood clues to perfect dose for devastating lung disease